These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9061296)

  • 1. Barrett's esophagus: ordering the events that lead to cancer.
    Reid BJ; Barrett MT; Galipeau PC; Sanchez CA; Neshat K; Cowan DS; Levine DS
    Eur J Cancer Prev; 1996 Dec; 5 Suppl 2():57-65. PubMed ID: 9061296
    [No Abstract]   [Full Text] [Related]  

  • 2. Barrett's esophagus: a model of human neoplastic progression.
    Neshat K; Sanchez CA; Galipeau PC; Cowan DS; Ramel S; Levine DS; Reid BJ
    Cold Spring Harb Symp Quant Biol; 1994; 59():577-83. PubMed ID: 7587115
    [No Abstract]   [Full Text] [Related]  

  • 3. Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression.
    Reid BJ; Prevo LJ; Galipeau PC; Sanchez CA; Longton G; Levine DS; Blount PL; Rabinovitch PS
    Am J Gastroenterol; 2001 Oct; 96(10):2839-48. PubMed ID: 11693316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barrett's oesophagus: from metaplasia to dysplasia and cancer.
    Fléjou JF
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i6-12. PubMed ID: 15711008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barrett's esophagus: evolutionary insights from genomics.
    Jankowski JA; Satsangi J
    Gastroenterology; 2013 Apr; 144(4):667-9. PubMed ID: 23439235
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
    Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
    Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis.
    Chao DL; Maley CC; Wu X; Farrow DC; Galipeau PC; Sanchez CA; Paulson TG; Rabinovitch PS; Reid BJ; Spitz MR; Vaughan TL
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1935-40. PubMed ID: 17035402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular markers and genetics in cancer development.
    Hormi-Carver K; Souza RF
    Surg Oncol Clin N Am; 2009 Jul; 18(3):453-67. PubMed ID: 19500736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of the MAD2, BUB1 and HSP27 genes in Barrett's oesophagus-their association with aneuploidy and neoplastic progression.
    Doak SH; Jenkins GJ; Parry EM; Griffiths AP; Baxter JN; Parry JM
    Mutat Res; 2004 Mar; 547(1-2):133-44. PubMed ID: 15013707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 gene mutations are rare in nondysplastic Barrett's esophagus.
    Novotna K; Trkova M; Pazdro A; Smejkal M; Soukupova A; Kodetova D; Smejkal P; Sedlacek Z
    Dig Dis Sci; 2006 Jan; 51(1):110-3. PubMed ID: 16416221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barrett's esophagus: the biology of neoplastic progression.
    Neshat K; Sanchez CA; Galipeau PC; Levine DS; Reid BJ
    Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D71-6. PubMed ID: 8013790
    [No Abstract]   [Full Text] [Related]  

  • 12. p53 and neoplastic progression in Barrett's esophagus.
    Reid BJ
    Am J Gastroenterol; 2001 May; 96(5):1321-3. PubMed ID: 11374661
    [No Abstract]   [Full Text] [Related]  

  • 13. Short-segment Barrett's esophagus associated with high-grade dysplasia.
    Morita K; Fujimori T; Ono Y; Masuyama H; Nakamura T; Terano A
    J Gastroenterol; 2002; 37(12):1083-5. PubMed ID: 12522544
    [No Abstract]   [Full Text] [Related]  

  • 14. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue.
    Galipeau PC; Prevo LJ; Sanchez CA; Longton GM; Reid BJ
    J Natl Cancer Inst; 1999 Dec; 91(24):2087-95. PubMed ID: 10601379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue.
    Walch A; Mueller J; Höfler H; Werner M
    J Natl Cancer Inst; 2000 Jul; 92(14):1182-3. PubMed ID: 10904093
    [No Abstract]   [Full Text] [Related]  

  • 16. 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy.
    Blount PL; Galipeau PC; Sanchez CA; Neshat K; Levine DS; Yin J; Suzuki H; Abraham JM; Meltzer SJ; Reid BJ
    Cancer Res; 1994 May; 54(9):2292-5. PubMed ID: 8162566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Barrett's carcinoma of the esophagus.
    Hölscher AH; Vallböhmer D; Bollschweiler E
    Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):347-54. PubMed ID: 19131920
    [No Abstract]   [Full Text] [Related]  

  • 18. Strategies for molecular intervention in esophageal cancers and their precursor lesions.
    Schrump DS; Nguyen DM
    Dis Esophagus; 1999; 12(3):181-5. PubMed ID: 10631909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
    Whitson MJ; Falk GW
    Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aneuploidy mechanisms in human colorectal preneoplastic lesions and Barrett's esophagus. Is there a role for K-ras and p53 mutations?
    Giaretti W
    Anal Cell Pathol; 1997; 15(2):99-117. PubMed ID: 9413595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.